Who are Caris Life Sciences, Inc.'s main suppliers?

Caris Life Sciences, Inc. (CAI) key suppliers include: Guardant Health, Inc.. View the full supplier network at chainsifter.com/chain/CAI.

Who are Caris Life Sciences, Inc.'s major customers?

Caris Life Sciences, Inc. (CAI) key customers include: BIOPHARMACEUTICAL-CUSTOMERS, INSTITUTIONS, PATIENTS, COLLABORATIVE-PARTNERS, END-USERS and 1 more. View the full customer network at chainsifter.com/chain/CAI.

What sector is Caris Life Sciences, Inc. in?

Caris Life Sciences, Inc. (CAI) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

CAI Supply Chain: Caris Life Sciences, Inc. Suppliers & Customers

1Suppliers

6Customers

2Debt Items

10Related Chains

Caris Life Sciences, Inc. Suppliers

Ticker	Name	Confidence	Evidence
GH	Guardant Health, Inc.	72%	Reciprocal relationship from GH graph: Reciprocal relationship from CAI graph: Reciprocal relationship from GH graph: biopsy space for therapy selection include Foundation Medicine, Inc., which was a…

Caris Life Sciences, Inc. Customers

Ticker	Name	Confidence	Evidence
BIOPHARMACEUTICAL-CUSTOMERS	BIOPHARMACEUTICAL-CUSTOMERS	90%	Pharma research and development services involving delivery of laboratory, strategic data, and research services to biopharmaceutical customers
INSTITUTIONS	INSTITUTIONS	90%	the Company recognizes revenue from the sale of its precision oncology solutions, provided to customers, including certain hospitals, institutions and patients
PATIENTS	PATIENTS	90%	the Company recognizes revenue from the sale of its precision oncology solutions, provided to customers, including certain hospitals, institutions and patients
COLLABORATIVE-PARTNERS	COLLABORATIVE-PARTNERS	85%	the Company recognizes revenue earned from the licenses of molecular data granted to the Company's collaborative partners
END-USERS	END-USERS	80%	the counterparty to these agreements meets the definition of a customer
GH	Guardant Health, Inc.	72%	Reciprocal relationship from GH graph: biopsy space for therapy selection include Foundation Medicine, Inc., which was acquired by Roche Holdings, Inc. in 2018; Caris Life Sciences, Inc.; Tempus AI, …

Caris Life Sciences, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
CAI-DEBT	Debt stack $431.0M	90%	Market cache reports total debt of $431.0M.
CAI-DEBT-8452	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2025-12-31.

Caris Life Sciences, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Caris Life Sciences, Inc..

Caris Life Sciences, Inc. Ownership

Holder	Name	Confidence	Evidence
CAI-OWNER-FMR-LLC	FMR LLC	90%	13F overlay lists FMR LLC as top holder; 203 tracked holders.

Caris Life Sciences, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
DGX	Quest Diagnostics Incorporated	100.00	2
TEM	Tempus AI, Inc.	100.00	2
MYGN	Myriad Genetics, Inc.	100.00	2
MRK	Merck & Co., Inc.	100.00	2
ABT	Abbott Laboratories	100.00	2
EXAS	Exact Sciences Corp	100.00	2
GH	Guardant Health, Inc.	100.00	2	['customer', 'supplier']
PSNL	Personalis, Inc.	36.29	1	['spend']
NATERA	NATERA	24.13	2
FLGT	Fulgent Genetics, Inc.	14.78	2

Caris Life Sciences, Inc. Supply Chain